Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis


Autoria(s): PARRA, E. R.; TEODORO, W. R.; MORAIS, J. de; KATAYAMA, M. L. H.; SOUZA, R. de; YOSHINARI, N. H.; CAPELOZZI, V. L.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2010

Resumo

Background Collagen V shows promise as an inducer of interstitial lung fibrosis in experimental systemic sclerosis (SSc). Materials and methods Remodelling of the pulmonary interstitium was evaluated based on the clinical data and open lung biopsies from 15 patients with SSc. Normal lung tissues obtained from eight individuals who died of traumatic injuries were used as control group. Immunofluorescence, immunohistochemistry, morphometry, tri-dimensional reconstruction and a real-time polymerase chain reaction were used to evaluate the quantity, structure and molecular chains of collagen V. The impact of these markers was tested on clinical data. Results The main difference in collagen V content between SSc patients and the control group was an increased, abnormal and distorted fibre deposition in the alveolar septa and the pre-acinar artery wall. The lungs from SSc patients presented [alpha 1(V)] and [alpha 2(V)] mRNA chain expression increased, but [alpha 2(V)] was proportionally increased compared with the control group. High levels of collagen V were inversely associated with vital capacity (r = -0.72; P = 0.002), forced vital capacity (r = -0.76; P < 0.001), forced expiratory volume in 1-s (r = -0.89; P < 0.001) and diffusing capacity for carbon monoxide (r = -0.62; P = 0.04). Conclusions Abnormal collagen V fibres are overproduced in lungs from SSc patients and may play an important role in the pathogenesis of the disease as this molecule regulates tissue collagen assembly. The aberrant histoarchitecture observed in SSc can be related to the overexpression of the [alpha 2(V)] gene of unknown origin.

Foundation for the Support of Research of the State of Sao Paulo (FAPESP)[2006/56579-9]

Foundation for the Support of Research of the State of Sao Paulo (FAPESP)[2008/56579-9]

National Council for Scientific and Technological Development (CNPq)

Medical Research Laboratories[LIM 17]

Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo HC-FM-USP

Identificador

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, v.40, n.2, p.110-120, 2010

0014-2972

http://producao.usp.br/handle/BDPI/22782

10.1111/j.1365-2362.2009.02224.x

http://dx.doi.org/10.1111/j.1365-2362.2009.02224.x

Idioma(s)

eng

Publicador

WILEY-BLACKWELL PUBLISHING, INC

Relação

European Journal of Clinical Investigation

Direitos

restrictedAccess

Copyright WILEY-BLACKWELL PUBLISHING, INC

Palavras-Chave #Collagen V #molecular biology #systemic sclerosis #three-dimensional reconstruction #INTERCELLULAR-ADHESION MOLECULE-1 #SCLERODERMA SKIN #INSITU HYBRIDIZATION #ELEVATED EXPRESSION #ELECTRON-MICROSCOPY #COL5A1 GENE #FIBROBLASTS #PATHOGENESIS #ACTIVATION #MECHANISMS #Medicine, General & Internal #Medicine, Research & Experimental
Tipo

article

original article

publishedVersion